Summary of Anticholinergic Pharmacotherapy Available for Overactive Bladder Dysfunction

被引:0
|
作者
Mangera, Altaf [1 ]
Chapple, Christopher R. [2 ]
机构
[1] Royal Hallamshire Hosp, Sheffield Teaching Hosp NHS Trust, Dept Urol Res, Sheffield, S Yorkshire, England
[2] Sheffield Hallam Univ, Royal Hallamshire Hosp, Room H26,H-Floor,Glossop Rd, Sheffield S10 2JF, S Yorkshire, England
关键词
Overactive bladder syndrome; Anticholinergic therapy; Oxybutynin; Solifenacin; Tolterodine; Fesoterodine; Darifenacin; Propiverine; Trospium;
D O I
10.1007/s11884-011-0114-7
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Bladder over activity affects many individuals worldwide. Anticholinergic therapy has become standard first-line pharmacotherapy for overactive bladder dysfunction after failure of conservative measures. Several different anticholinergic agents are currently utilized in clinical practice. In this article, we review the mechanism of action of these drugs. This review aims to summarize the contemporary evidence base behind the use of these agents in terms of efficacy, safety, and patient satisfaction. Anticholinergic agents lead to improvements in symptoms of urgency, frequency, and urgency incontinence; however, there are associated side effects related to dry mouth, pruritus, constipation, and the central nervous system.
引用
收藏
页码:51 / 58
页数:8
相关论文
共 50 条
  • [31] Pharmacotherapy for detrusor instability and symptoms of the overactive bladder
    Chapple, C
    Jonas, U
    WORLD JOURNAL OF UROLOGY, 2001, 19 (05) : 293 - 293
  • [32] Pharmacotherapy for detrusor instability and symptoms of the overactive bladder
    Christopher Chapple
    Udo Jonas
    World Journal of Urology, 2001, 19 : 293 - 293
  • [33] Combination Pharmacotherapy for Treatment of Overactive Bladder (OAB)
    Ahmed El-Zawahry
    Current Urology Reports, 2019, 20
  • [34] Pharmacotherapy of the overactive bladder and advances in drug delivery
    Cannon, TW
    Chancellor, MB
    CLINICAL OBSTETRICS AND GYNECOLOGY, 2002, 45 (01): : 205 - 217
  • [35] Current and future pharmacotherapy for treating overactive bladder
    Thiagamoorthy, Ganesh
    Cardozo, Linda
    Robinson, Dudley
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (10) : 1317 - 1325
  • [36] Improving the Tolerability of Anticholinergic Agents in the Treatment of Overactive Bladder
    Roger Dmochowski
    Drug Safety, 2005, 28 : 583 - 600
  • [37] Trospilim chloride (Sanctura):: Another anticholinergic for overactive bladder
    不详
    OBSTETRICS AND GYNECOLOGY, 2005, 105 (02): : 431 - 432
  • [38] Nonpharmacologic vs. anticholinergic therapies for overactive bladder
    Kripke, Clarissa
    AMERICAN FAMILY PHYSICIAN, 2007, 75 (09) : 1336 - 1336
  • [39] Which anticholinergic drug for overactive bladder symptoms in adults
    Hay-Smith, J
    Herbison, P
    Ellis, G
    Morris, A
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2005, (03):
  • [40] Refractory overactive bladder: Beyond oral anticholinergic therapy
    Glinski, Ronald W.
    Siegel, Steven
    INDIAN JOURNAL OF UROLOGY, 2007, 23 (02) : 166 - 173